Galectin-10 Is Released in the Nasal Lavage Fluid of Patients with Aspirin-Sensitive Respiratory Disease

<table>Relative quantification (RU:Relative Units) of galectin-10 gene expression in PBMC with respect to healthy controls (HC) in patients with aspirin sensitive respiratory disease (ASRD) and aspirin-tolerant asthma (ATA).</table>

The Scientific World Journal

fig1

Figure 1

Figure 1: Galectin-10 Is Released in the Nasal Lavage Fluid of Patients with Aspirin-Sensitive Respiratory Disease 